NCT03292315View on ClinicalTrials.gov

Once Weekly GLP-1 in Persons With Spinal Cord Injury

PHASE4CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 16, 2018

Primary Completion Date

March 1, 2020

Study Completion Date

March 1, 2023

Conditions
Spinal Cord InjuriesInsulin ResistancePre DiabetesObesity
Interventions
DRUG

Semaglutide 1MG Injection [Ozempic]

Once weekly injection of 1mg of Semaglutide.

OTHER

No Intervention

No injection will be administered

Trial Locations (1)

07052

Kessler Institute for Rehabilitation, West Orange

All Listed Sponsors
collaborator

Kessler Institute for Rehabilitation

INDUSTRY

lead

James J. Peters Veterans Affairs Medical Center

FED

NCT03292315 - Once Weekly GLP-1 in Persons With Spinal Cord Injury | Biotech Hunter | Biotech Hunter